OncoMed Pharmaceuticals Initiates Second Phase 1b Clinical Trial for OMP …

Published February 19, 2014

OncoMed Pharmaceuticals Initiates Second Phase 1b Clinical Trial for OMP …
OMP-54F28 holds the potential to make a real difference for these patients as it was designed to attack so-called cancer stem cells that can generate new cancer cells and are particularly resistant to currently available cancer drugs." Five additional … Read more on GlobeNewswire (press release)

Karen E. Aspry and Charles B. Eaton: Fight heart disease with shared decisions …
The new Cholesterol Treatment Guidelines released by the American College of Cardiology and American Heart Association last November generated wide discussion. What was … For those with known atherosclerosis (plaque buildup in coronary, peripheral … Read more on The Providence Journal

New Crohn's disease treatment trial now open to those in U.S.
The company notes all of the patients were treated under a "compassionate" use program versus a controlled blinded clinical trial, meaning the results don't prove the drug's effectiveness. The drug was reported to be well tolerated among 121 patients … Read more on eMaxHealth